Pdt Partners, LLC Alector, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$4.19 - $6.23 $63,210 - $93,985	-15,086 Reduced 26.22%	42,444 $192,000
Q1 2024 May 15, 2024	BUY	$5.69 - $8.08 $263,862 - $374,693	46,373 Added 415.64%	57,530 $346,000
Q4 2023 Feb 14, 2024	SELL	$3.77 - $8.39 $77,662 - $172,834	-20,600 Reduced 64.87%	11,157 $89,000
Q3 2023 Nov 14, 2023	SELL	$5.2 - $8.77 $78,322 - $132,093	-15,062 Reduced 32.17%	31,757 $205,000
Q2 2023 Aug 14, 2023	SELL	$5.86 - $7.93 $172,700 - $233,705	-29,471 Reduced 38.63%	46,819 $281,000
Q1 2023 May 15, 2023	BUY	$5.85 - $9.84 $120,691 - $203,009	20,631 Added 37.07%	76,290 $472,000
Q4 2022 Feb 14, 2023	BUY	$6.88 - $9.55 $261,075 - $362,393	37,947 Added 214.24%	55,659 $513,000
Q3 2022 Nov 14, 2022	SELL	$8.19 - $13.2 $142,899 - $230,313	-17,448 Reduced 49.62%	17,712 $168,000
Q2 2022 Aug 15, 2022	BUY	$7.65 - $14.24 $57,099 - $106,287	7,464 Added 26.95%	35,160 $357,000
Q1 2022 May 16, 2022	SELL	$13.02 - $20.78 $373,621 - $596,302	-28,696 Reduced 50.89%	27,696 $395,000
Q4 2021 Feb 14, 2022	SELL	$19.35 - $25.54 $883,733 - $1.17 Million	-45,671 Reduced 44.75%	56,392 $1.16 Million
Q3 2021 Nov 15, 2021	BUY	$21.65 - $39.49 $207,038 - $377,642	9,563 Added 10.34%	102,063 $2.33 Million
Q2 2021 Aug 16, 2021	SELL	$15.5 - $22.48 $8,819 - $12,791	-569 Reduced 0.61%	92,500 $1.93 Million
Q1 2021 May 17, 2021	SELL	$14.84 - $22.23 $717,603 - $1.07 Million	-48,356 Reduced 34.19%	93,069 $1.87 Million
Q4 2020 Feb 16, 2021	SELL	$9.4 - $16.7 $311,826 - $553,989	-33,173 Reduced 19.0%	141,425 $2.14 Million
Q3 2020 Nov 16, 2020	BUY	$10.54 - $24.96 $1.67 Million - $3.94 Million	157,996 Added 951.67%	174,598 $1.84 Million
Q2 2020 Aug 14, 2020	BUY	$21.87 - $33.11 $363,085 - $549,692	16,602 New	16,602 $406,000

Others Institutions Holding ALEC

# of Institutions

168

Shares Held

57.8M

Call Options Held

146K

Put Options Held

90.8K

View Full List

About Alector, Inc.

Ticker ALEC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 82,563,904
Market Cap $159M
Description
Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...

More about ALEC

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account